|
Diabetes, Vol 49, Issue 12 2094-2101, Copyright © 2000 by American Diabetes Association
A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia
C Weyer, RL Hanson, PA Tataranni, C Bogardus and RE Pratley
Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85016, USA. cweyer@phx.niddk.nih.gov
Fasting hyperinsulinemia is a widely used surrogate measure of insulin
resistance and predicts type 2 diabetes in various populations. Whether
fasting hyperinsulinemia predicts diabetes independent of insulin
resistance is unknown. In 319 Pima Indians with normal glucose tolerance,
fasting plasma insulin concentration and insulin-stimulated glucose
disposal (M) (hyperinsulinemic clamp) were inversely related, but at any
given M, there was substantial variation, with some subjects being
hyperinsulinemic and others being hypoinsulinemic relative to their degree
of insulin sensitivity. In 262 of the 319 subjects followed prospectively
over 6.4 +/- 3.9 years, a high fasting plasma insulin concentration was a
significant independent predictor of diabetes, in addition to low M and low
acute insulin response (AIR) (intravenous glucose challenge). In 161 of the
319 subjects with follow-up measurements of M and AIR (5.1 +/- 3.9 years),
a high relative fasting plasma insulin concentration predicted a decline in
AIR but not in M before the onset of diabetes. The adjusted fasting plasma
insulin concentration was a familial trait (heritability of 0.52) and in a
genome-wide scan, there was suggestive evidence of linkage (logarithm of
odds score 1.77) to a region on chromosome 3q, which harbors the gene
encoding GLUT2. These results provide the first prospective evidence in
humans that fasting hyperinsulinemia itself has a primary role in the
pathogenesis of diabetes, independent of insulin resistance. Whether
amelioration of basal insulin hypersecretion will prevent diabetes remains
to be elucidated.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. HARRIS, S. BISWAS, J. SINGH, S. DENNISON, and D. A PHOENIX
Calpains and Their Multiple Roles in Diabetes Mellitus
Ann. N.Y. Acad. Sci.,
November 1, 2006;
1084(1):
452 - 480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Sinaiko, J. Steinberger, A. Moran, C.-P. Hong, R. J. Prineas, and D. R. Jacobs Jr
Influence of Insulin Resistance and Body Mass Index at Age 13 on Systolic Blood Pressure, Triglycerides, and High-Density Lipoprotein Cholesterol at Age 19
Hypertension,
October 1, 2006;
48(4):
730 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Nigro, N. Osman, A. M. Dart, and P. J. Little
Insulin Resistance and Atherosclerosis
Endocr. Rev.,
May 1, 2006;
27(3):
242 - 259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kahn, J. Buse, E. Ferrannini, and M. Stern
The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care,
September 1, 2005;
28(9):
2289 - 2304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Rabaglia, M. P. Gray-Keller, B. L. Frey, M. R. Shortreed, L. M. Smith, and A. D. Attie
{alpha}-Ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice
Am J Physiol Endocrinol Metab,
August 1, 2005;
289(2):
E218 - E224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Balkau
Epidemiology of the metabolic syndrome and the RISC study
Eur. Heart J. Suppl.,
June 1, 2005;
7(suppl_D):
D6 - D9.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ferrannini, A. Gastaldelli, Y. Miyazaki, M. Matsuda, A. Mari, and R. A. DeFronzo
{beta}-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis
J. Clin. Endocrinol. Metab.,
January 1, 2005;
90(1):
493 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Remedi, Joseph. C. Koster, K. Markova, S. Seino, T. Miki, B. L. Patton, M. L. McDaniel, and C. G. Nichols
Diet-Induced Glucose Intolerance in Mice With Decreased {beta}-Cell ATP-Sensitive K+ Channels
Diabetes,
December 1, 2004;
53(12):
3159 - 3167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. T. Tigno, G. Gerzanich, and B. C. Hansen
Age-Related Changes in Metabolic Parameters of Nonhuman Primates
J. Gerontol. A Biol. Sci. Med. Sci.,
November 1, 2004;
59(11):
1081 - 1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. VrbIkova, D. Cibula, K. Dvorakova, S. Stanicka, G. Sindelka, M. Hill, M. Fanta, K. Vondra, and J. Skrha
Insulin Sensitivity in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
June 1, 2004;
89(6):
2942 - 2945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. V. de Courten, C. Weyer, N. Stefan, M. Horton, A. DelParigi, P. Havel, C. Bogardus, and P. A. Tataranni
Parasympathetic Blockade Attenuates Augmented Pancreatic Polypeptide But Not Insulin Secretion in Pima Indians
Diabetes,
March 1, 2004;
53(3):
663 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Goran, R. N. Bergman, Q. Avila, M. Watkins, G. D. C. Ball, G. Q. Shaibi, M. J. Weigensberg, and M. L. Cruz
Impaired Glucose Tolerance and Reduced {beta}-Cell Function in Overweight Latino Children with a Positive Family History for Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
January 1, 2004;
89(1):
207 - 212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Meigs, D. C. Muller, D. M. Nathan, D. R. Blake, and R. Andres
The Natural History of Progression From Normal Glucose Tolerance to Type 2 Diabetes in the Baltimore Longitudinal Study of Aging
Diabetes,
June 1, 2003;
52(6):
1475 - 1484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E. A. Eckman, M. P. Frosch, C. B. Eckman, R. E. Tanzi, D. J. Selkoe, and S. Guenette
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta -protein, and the beta -amyloid precursor protein intracellular domain in vivo
PNAS,
April 1, 2003;
100(7):
4162 - 4167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Bodkin, T. M. Alexander, H. K. Ortmeyer, E. Johnson, and B. C. Hansen
Mortality and Morbidity in Laboratory-maintained Rhesus Monkeys and Effects of Long-term Dietary Restriction
J. Gerontol. A Biol. Sci. Med. Sci.,
March 1, 2003;
58(3):
B212 - 219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Greenway, F. L. Greenway III, and S. Klein
Effects of Obesity Surgery on Non-Insulin-Dependent Diabetes Mellitus
Arch Surg,
October 1, 2002;
137(10):
1109 - 1117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Salbe, C. Weyer, R. S. Lindsay, E. Ravussin, and P. A. Tataranni
Assessing Risk Factors for Obesity Between Childhood and Adolescence: I. Birth Weight, Childhood Adiposity, Parental Obesity, Insulin, and Leptin
Pediatrics,
August 1, 2002;
110(2):
299 - 306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kooptiwut, S. Zraika, A. W. Thorburn, M. E. Dunlop, R. Darwiche, T. W. Kay, J. Proietto, and S. Andrikopoulos
Comparison of Insulin Secretory Function in Two Mouse Models with Different Susceptibility to {beta}-Cell Failure
Endocrinology,
June 1, 2002;
143(6):
2085 - 2092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Surwit, R. B. Williams, I. C. Siegler, J. D. Lane, M. Helms, K. L. Applegate, N. Zucker, M. N. Feinglos, C. M. McCaskill, and J. C. Barefoot
Hostility, Race, and Glucose Metabolism in Nondiabetic Individuals
Diabetes Care,
May 1, 2002;
25(5):
835 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. B.T. Christesen, B. B. Jacobsen, S. Odili, C. Buettger, A. Cuesta-Munoz, T. Hansen, K. Brusgaard, O. Massa, M. A. Magnuson, C. Shiota, et al.
The Second Activating Glucokinase Mutation (A456V): Implications for Glucose Homeostasis and Diabetes Therapy
Diabetes,
April 1, 2002;
51(4):
1240 - 1246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Vague and L. Nguyen
Rationale and Methods for the Estimation of Insulin Secretion in a Given Patient: From Research to Clinical Practice
Diabetes,
February 1, 2002;
51(90001):
S240 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Inzucchi
Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review
JAMA,
January 16, 2002;
287(3):
360 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Khan, P. B. Goforth, M. Zhang, and L. S. Satin
Insulin Activates ATP-Sensitive K+ Channels in Pancreatic {beta}-Cells Through a Phosphatidylinositol 3-Kinase-Dependent Pathway
Diabetes,
October 1, 2001;
50(10):
2192 - 2198.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Stumvoll, A. Fritsche, A. Madaus, N. Stefan, M. Weisser, F. Machicao, and H. Haring
Functional Significance of the UCSNP-43 Polymorphism in the CAPN10 Gene for Proinsulin Processing and Insulin Secretion in Nondiabetic Germans
Diabetes,
September 1, 2001;
50(9):
2161 - 2163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R. E. Pratley, and P. A. Tataranni
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
J. Clin. Endocrinol. Metab.,
May 1, 2001;
86(5):
1930 - 1935.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the American Diabetes Association.
|
|
| |
|